SOURCE LEGAL is an essential daily research tool for attorneys engaged in China's pharmaceutical and biotechnology industry. SOURCE LEGAL integrates data covering patents (US, China, and PCT), patent invalidations, trademarks, lawsutis, judges, courts, law firms, pharmaceutical companies, and patent agents, enabling a legal professional to view the legal landscape from a client or pharmaceutical product perspective.

Customized alerts allow legal professionals to track products, patents, and lawsuits. Integrated tools allow for in depth research of the historical actions of judges and courts, allowing for more informed decision marking on where to file lawsuits. SOURCE SELECT news and other content.

Features
Publications:
Our Weekly and Monthly publications are a simple and efficient way to keep tabs on big picture industry trends in China.  Put the news in context with proprietary articles and analysis by GBI experts.

News:
China's premier pharmaceutical and biotechnology newswire with daily summary briefs covering key events. Customizable email alerts track news, policy, regulatory, and pipeline for any drug or company.

Drug Intelligence:
We track every single SFDA approved drug in China, from the first IND, through to generic competition. See every single company targeting your molecules and their level of pricing and reimbursement support on a provincial level.

Legal:
Track US, China, and PCT patent invalidations, trademarks, lawsuits, judges, courts, law firms, pharmaceutical companies, and patent agents. An invaluable tool for in-house legal research.